Testing effectiveness (Phase 2)Study completedNCT03866967What this trial is testingAnti-PD-1 AK105 in Patients With Metastatic Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Carcinoma Akeso 130
Large-scale testing (Phase 3)Study completedNCT01866319What this trial is testingStudy to Evaluate the Safety and Efficacy of Two Different Dosing Schedules of Pembrolizumab (MK-3475) Compared to Ipilimumab in Participants With Advanced Melanoma (MK-3475-006/KEYNOTE-006)Who this might be right forMelanoma Merck Sharp & Dohme LLC 834
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07022301What this trial is testingSintilimab Plus Anlotinib as Second or Further-line Therapy for ES-SCLC Who Have Progressed After Anti-PD-1/L1 TherapyWho this might be right forSmall Cell Lung Cancer Extensive StageResistance to Immunotherapy First Affiliated Hospital of Wannan Medical College 25
Testing effectiveness (Phase 2)Study completedNCT03463681What this trial is testingCaBozantinib in Patients With Advanced or Unresectable Renal cEll cArcinomaWho this might be right forMetastatic Renal Cell Carcinoma Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 49
Testing effectiveness (Phase 2)UnknownNCT03993626What this trial is testingA Trial of CXD101 in Combination With Nivolumab in Patients With Metastatic Microsatellite-Stable Colorectal CancerWho this might be right forColorectal Neoplasms Malignant Celleron Therapeutics Ltd. 55
Not applicableUnknownNCT06335147What this trial is testingPD1 Antibody Combined With mFOLFOX6 Neoadjuvant Therapy for Advanced Resectable Metastatic Colon CancerWho this might be right forMetastatic Colon Cancer Henan Cancer Hospital 23
Not applicableLooking for participantsNCT06887348What this trial is testingAssess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3Who this might be right forMelanomaMetastatic MelanomaAdvanced Solid Tumor+1 more Replimune Inc. 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04295317What this trial is testingPD-1 Antibody (SHR-1210) Plus Capecitabine in Patients with Intrahepatic Cholangiocarcinoma After SurgeryWho this might be right forIntrahepatic Cholangiocarcinoma Shanghai Zhongshan Hospital 65
Post-approval studies (Phase 4)UnknownNCT04040491What this trial is testingPD-1 Antibody, Chidamide, Lenalidomide and Gemcitabine for Peripheral T-cell LymphomaWho this might be right forPeripheral T-cell Lymphoma Mingzhi Zhang 100
Testing effectiveness (Phase 2)UnknownNCT03972722What this trial is testingStudy of GLS-010 Injection in Patients With Recurrent or Metastatic Cervical CancerWho this might be right forCervical Cancer Guangzhou Gloria Biosciences Co., Ltd. 89
Not applicableLooking for participantsNCT06904131What this trial is testingA Phase I Clinical Trial of CAR-T Cells for Advanced Gynecological Solid TumorsWho this might be right forGynecological Solid Tumors Obstetrics & Gynecology Hospital of Fudan University 20
Early research (Phase 1)Study completedNCT03547037What this trial is testingEvaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ-63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination With Erdafitinib in Japanese Participants With Advanced Solid CancersWho this might be right forNeoplasm Janssen Pharmaceutical K.K. 22
Early research (Phase 1)WithdrawnNCT04605614What this trial is testing64Cu-DOTA-pembrolizumab PET for the Study of PD1 ExpressionWho this might be right forHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm City of Hope Medical Center
Not applicableNot Yet RecruitingNCT06682247What this trial is testingA Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal CancerWho this might be right forColorectal Cancer Metastatic Feng Wang 200
Testing effectiveness (Phase 2)Looking for participantsNCT06635785What this trial is testingSafety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor OncoC4, Inc. 204
Not applicableLooking for participantsNCT06154668What this trial is testingProfiling of Circulating Immune Cells to Uncover Response Signatures to Anti-PD1 Immunotherapy in Melanoma PatientsWho this might be right forMelanoma University Hospital, Grenoble 707
Testing effectiveness (Phase 2)Looking for participantsNCT06981325What this trial is testingEvaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) PatientsWho this might be right forBasal Cell Carcinoma (BCC)First Line Treatment Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 34
Early research (Phase 1)UnknownNCT03468751What this trial is testingPhase 1 Study of HLX10, a Monoclonal Antibody Targeting Programmed Death-1 (PD-1) in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor Henlix, Inc 30
Not applicableActive Not RecruitingNCT06796231What this trial is testingEfficacy of PD-1 Monoclonal Antibody in the Treatment of PhaeohyphomycosisWho this might be right forPhaeohyphomycosis Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 1
Not applicableLooking for participantsNCT06874257What this trial is testingTargeting Acute Myeloid Leukemia Immunosuppressive Microenvironment by combinedIDO1 Inhibition and PD-1 BlockadeWho this might be right forAML (Acute Myelogenous Leukemia) IRCCS Azienda Ospedaliero-Universitaria di Bologna 20